Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience

BACKGROUND: Persistent significant proteinuria has been associated with increased risk of progression to end-stage kidney disease in patients with idiopathic membranous nephropathy (IMN). Rituximab (RTX) therapy has given encouraging results in IMN, but most of the studies have used a higher dose, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagchi, Soumita, Subbiah, Arun Kumar, Bhowmik, Dipankar, Mahajan, Sandeep, Yadav, Raj Kanwar, Kalaivani, Mani, Singh, Geetika, Dinda, Amit, Kumar Agarwal, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Clinical Nephrology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007352/
https://www.ncbi.nlm.nih.gov/pubmed/29942496
http://dx.doi.org/10.1093/ckj/sfx105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007352/
https://www.ncbi.nlm.nih.gov/pubmed/29942496
http://dx.doi.org/10.1093/ckj/sfx105

Ejemplares similares